Ebay, Quest Diagnostics, Fastenal, Chubb trade in or around buy points after earnings. TG Therapeutics breaks out.
Why CB Stock advanced +1.91% Today — RQD Quant Desk Flash
Chubb Limited (CB) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why CB Stock advanced +1.91% Today — RQD Quant Desk Flash
Chubb Limited (CB) advanced +1.91% to $362.28 as options desks priced 62% call premium vs. 38% put protection around the $355 max-pain magnet. Solid 41% profit margin (8% return on capital), mixed timing at 13x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 93% of its 52-week range ($273.35 – $369) with RSI-14 at 65.7 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $15.4M in bullish call flow vs. $9.5M in put flow (Put/Call 0.62x, implied earnings swing ±6.7%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 44% gross margin and $10.1B annual free cash flow.
Morningstar and Altria Group rose to new highs after both companies reported better-than-expected earnings this week.
EG's Q3 2026 earnings miss estimates as catastrophe losses and reserve development hurt underwriting profits despite record investment income.
Chubb (NYSE:CB) has reshaped its Global Claims leadership with several senior appointments announced in its Global Claims organization. Lisa Wilson has been named Head of North America Claims, taking responsibility for c
Willis Towers Watson beats Q3 earnings estimates as organic growth, expanding margins and strong cash flow support its 2026 outlook and AI-driven savings plan.
2026-10-28. The following slide deck was published by Chubb Limited in conjunction with their 2026 Q3 earnings call.
BRK.B's shares are trading above the 50-day SMA, backed by strong liquidity, diversified earnings and positive analyst sentiment. Is the rally sustainable?
ACGL's Q3 2026 earnings beat estimates on higher investment income, but lower premiums, rising catastrophe losses and weaker underwriting weighed on results.
CB vs. TKOMY: Which Stock Is the Better Value Option?
TD Cowen analyst Andrew Kligerman maintains Chubb (NYSE:CB) with a Hold and raises the price target from $360 to $379.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live CB Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
CB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CB today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CB. Explore sector supply chains on /butterfly.
CB Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CB stock moving today?
Why CB Stock advanced +1.91% Today — RQD Quant Desk Flash. Solid 41% profit margin (8% return on capital), mixed timing at 13x P/E—hold if owned, no rush to chase.